AI Verdict
IMAX has stronger fundamentals based on our AI analysis.
IMKTA vs IMAX Fundamental Comparison
| Metric | IMKTA | IMAX |
|---|---|---|
| Revenue | $1.4B | $410.2M |
| Net Income | $28.1M | $34.9M |
| Net Margin | 2.0% | 8.5% |
| ROE | 1.7% | 10.3% |
| ROA | 1.1% | 3.9% |
| Current Ratio | 3.36x | N/A |
| Debt/Equity | 0.30x | 0.00x |
| EPS | N/A | $0.63 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IMKTA vs IMAX: Frequently Asked Questions
Is IMKTA or IMAX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IMAX has stronger fundamentals. IMKTA is rated SELL (72% confidence) while IMAX is rated HOLD (78% confidence). This is not investment advice.
How does IMKTA compare to IMAX fundamentally?
INGLES MARKETS INC has ROE of 1.7% vs IMAX CORP's 10.3%. Net margins are 2.0% vs 8.5% respectively.
Which stock pays higher dividends, IMKTA or IMAX?
IMKTA has a dividend yield of N/A or no dividend while IMAX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IMKTA or IMAX for long term?
For long-term investing, consider that IMKTA has SELL rating with 72% confidence, while IMAX has HOLD rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IMKTA vs IMAX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IMKTA vs IMAX, the AI consensus favors IMAX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.